Alcon (ALC) Stock Forecast & Price Target

$84.76 +0.58 (+0.69%)

(As of 12/20/2024 05:15 PM ET)

Alcon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
0

Hold
3

Buy
11

Based on 14 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, and 11 have given a buy rating for ALC.

Consensus Price Target

$102.72
21.19% Upside

According to the 14 analysts' twelve-month price targets for Alcon, the average price target is $102.72. The highest price target for ALC is $110.00, while the lowest price target for ALC is $85.00. The average price target represents a forecasted upside of 21.19% from the current price of $84.76.

Get the Latest News and Ratings for ALC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alcon and its competitors.

ALC Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)	9 Buy rating(s)
Hold	3 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$102.72	$102.63	$99.74	$88.53
Forecasted Upside	21.19% Upside	20.03% Upside	2.32% Upside	14.75% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Alcon Stock vs. The Competition

Type	Alcon	Medical Companies	S&P 500
Consensus Rating Score	2.79	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	21.19% Upside	25,828.59% Upside	14.54% Upside
News Sentiment Rating	Neutral News See Recent ALC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$103.00 ➝ $108.00	+28.76%
11/26/2024	BTIG Research 2 of 5 stars	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
10/15/2024	KeyCorp 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$103.00 ➝ $107.00	+10.08%
10/10/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	I. Kirby Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral
9/10/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Reynolds-Clar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Outperform
8/22/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$94.00 ➝ $105.00	+9.88%
Get the Latest News and Ratings for ALC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.
8/22/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$103.00 ➝ $110.00	+16.25%
8/22/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$104.00 ➝ $110.00	+16.25%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underweight ➝ Equal Weight	$65.00 ➝ $85.00	-7.35%
5/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$95.00 ➝ $100.00	+12.02%
5/15/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $105.00	+17.62%
4/10/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.95%
3/4/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$90.00 ➝ $100.00	+16.31%
2/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$93.00 ➝ $96.60	+13.10%
11/20/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$94.00 ➝ $88.00	+23.40%
8/17/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$79.80 ➝ $89.30	+11.29%
3/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:34 PM ET.

Should I Buy Alcon Stock? ALC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

Alcon
Bull Case

Here are some ways that investors could benefit from investing in Alcon Inc.:

Alcon Inc. has shown a strong fifty-two week performance of 26.72%, indicating a positive trend in its stock price over the past year, which can attract investors looking for growth.
The current stock price is $91.98, which reflects the company's market valuation and can be seen as a point of entry for potential investors.
With an average daily volume of 695,900 shares, there is significant trading activity, suggesting liquidity and ease of buying or selling shares.
Institutional ownership is at 72.64%, indicating that a large portion of the company is held by institutional investors, which can be a sign of confidence in the company's future prospects.
The short percentage of float is relatively low at 0.65%, suggesting that there is not a significant amount of bearish sentiment against the stock, which can be a positive indicator for potential investors.

Alcon
Bear Case

Investors should be bearish about investing in Alcon Inc. for these reasons:

There has been a month-to-month decrease in shares shorted, from 3,430,000 to 3,160,000, which may indicate a lack of confidence in the stock's upward movement.
The institutional ownership percentage dropped to 0%, which could suggest a lack of confidence from institutional investors, potentially leading to volatility.
Despite a positive performance, the average daily volume has decreased from 810,500 to 695,900, indicating reduced trading interest, which could affect liquidity.
The days to cover has increased slightly to 4.5, which means it would take longer for short sellers to cover their positions, potentially indicating bearish sentiment.
The month-to-month change percentage in shares shorted is negative at -7.87%, which could reflect a trend of decreasing investor confidence in the stock's performance.

ALC Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $102.72, with a high forecast of $110.00 and a low forecast of $85.00.
: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALC shares.
: According to analysts, Alcon's stock has a predicted upside of 21.19% based on their 12-month stock forecasts.
: Over the previous 90 days, Alcon's stock had 1 upgrade and 1 downgrade by analysts.
: Alcon has been rated by research analysts at BTIG Research, KeyCorp, Needham & Company LLC, and Redburn Atlantic in the past 90 days.
: Analysts like Alcon less than other "medical" companies. The consensus rating score for Alcon is 2.79 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ALC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

This page (NYSE:ALC) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alcon (ALC) Stock Forecast & Price Target